Tamoxifen increases nuclear respiratory factor 1 transcription by activating estrogen receptor β and AP‐1 recruitment to adjacent promoter binding sites-Reference-Cited by-同舟云学术

Tamoxifen increases nuclear respiratory factor 1 transcription by activating estrogen receptor β and AP‐1 recruitment to adjacent promoter binding sites

Published:2011-01-13 Issue:4 Volume:25 Page:1402-1416
ISSN:0892-6638
Container-title:The FASEB Journal
language:en
Short-container-title:FASEB j.

Author:

Ivanova Margarita M.¹,Luken Kristen H.¹,Zimmer Amber S.¹,Lenzo Felicia L.¹,Smith Ryan J.¹,Arteel Maia W.¹,Kollenberg Tara J.¹,Mattingly Kathleen A.¹,Klinge Carolyn M.¹

Affiliation:

1. Department of Biochemistry and Molecular BiologyCenter for Genetics and Molecular Medicine, Center for Environmental Genomics and Integrative Biology, University of Louisville School of Medicine Louisville Kentucky USA

Funder

National Institutes of Health

Publisher

Wiley

Subject

Genetics,Molecular Biology,Biochemistry,Biotechnology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1096/fj.10-169029

Reference73 articles.

1. A Century of Deciphering the Control Mechanisms of Sex Steroid Action in Breast and Prostate Cancer: The Origins of Targeted Therapy and Chemoprevention

2. American Society of Clinical Oncology Clinical Practice Guideline: Update on Adjuvant Endocrine Therapy for Women With Hormone Receptor–Positive Breast Cancer

3. Influence of Cellular ERα/ERβ Ratio on the ERα-Agonist Induced Proliferation of Human T47D Breast Cancer Cells